Abstract
Experimentally a better therapeutic index has been found for adriamycin than daunomycin [4] and in preliminary clinical trials [1] adriamycin proved to be more active than daunomycin in solid tumors in general, and in lung tumors in particular [2].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bonadonna, G., Monfardini, S., De Lena, M., Fossati-Bellani, F.: Brit. med. J. 1969 III, 503–506.
Bonadonna, G., De Lena, M., Beretta, G.: Europ. J. Cancer 7, 365–367 (1971).
Di Fronzo, G., Gambetta, R.A., Bonadonna, G.: Preliminary studies on the distribution and excretion of tritiated adriamycin in man. Comm. Europ. Meet, and 6 Meet. Therapeutic Chemistry, Bruxelles, 14–Sept. 1970.
Di Marco, A., Gaetani, M., Scarpinato, B.: Adriamycin (NSC — 123,127): a new antibiotic with antitumor activity. Cancer Chemother. Rep. 53, 33–37 (1969).
Karnofsky, D. A.: Clin. Pharm. Ther. 2, 709–712 (1961).
Yesair, D.: Personal communication.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1972 Springer-Verlag, Berlin Heidelberg
About this paper
Cite this paper
Praga, C. (1972). Cooperative Clinical Study on Adriamycin in Advanced Lung Tumors. In: Carter, S.K., Marco, A.D., Ghione, M., Krakoff, I.H., Mathé, G. (eds) International Symposium on Adriamycin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-95227-2_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-95227-2_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-95229-6
Online ISBN: 978-3-642-95227-2
eBook Packages: Springer Book Archive